Can Pharmaceutical Companies Use Aging Biology to Develop Drugs for Age-Related Disorders?
The University of Copenhagen is one of the most unique places in Denmark. It is not only one of Scandinavia’s oldest universities, but also one of top universities worldwide. The University has been home to 39 Nobel laureates and boasts a center for healthy ageing, which houses the Biology of Aging Lab. The University of Copenhagen will host the 8th Annual Aging Research and Drug Discovery Meeting (ARDD) in September 2021.
The ARDD conference, which was held in the Ceremonial Hall at the University for the second year running, was the largest biopharmaceutical and aging conference in the world.
The conference took place between August 31 and September 3. It brought together experts in the field, with a focus on drug discovery, biomarker research, and aging research. My regular readers know that aging is a trend that’s emerging in the biopharmaceutical sector. The field is a new one, and ARDD was the first conference to bring together representatives from the biopharmaceutical industry, academics, clinical researchers, venture capitalists and pharmaceutical companies.
In 2014, the first ARDD conference was held at Basil in Switzerland. The meeting, which was then called the Aging Forum, was part of both the MipTec and Basel Life conferences. The conference’s goal was to bring together a wide range of stakeholders, including the pharmaceutical industry, academics, investors and startups, all while maintaining high levels of scientific credibility.
Full Story
Source:
https://intechcompany.blogspot.com/2022/01/can-pharmaceutical-companies-use-basic.html
